Tackling the biggest challenge in healthcare
Our focus is on chronic diseases

 

89m people
89.1 million people with the major 4 chronic conditions living in US. This figure is growing due to ageing populations

 

$1.7tn spend
$1.7 trillion already being spent each year fighting chronic conditions in US

 

Tackling the biggest challenge in healthcare


Our focus is on chronic diseases


 

89m people


89.1 million people with the major 4 chronic conditions living in US. This figure is growing due to ageing populations

 

$1.7tn spend


$1.7 trillion already being spent each year fighting chronic conditions in US

 

 

An entrepreneur-led senior management team
with extensive biomedical, healthcare and commercial experience.


  • François Martelet M.D.

  • Ian Postlethwaite

  • Vijay Barathan M.D.

An entrepreneur-led senior management team with extensive biomedical, healthcare and commercial experience.




  • François Martelet M.D.

  • Ian Postlethwaite

  • Vijay Barathan M.D.

 

Holistic healthcare investment
Building businesses that fight chronic diseases on three fronts

 

Holistic Healthcare Investment

 

Digital Health

Using data to provide clinical grade actionable insight.

Diagnostics

Novel highly specific tests to provide earlier diagnosis, accurate monitoring of disease progression and the ability to personalize therapy based on an understanding of an individuals ability to respond to treatment.

Therapeutics

Novel mechanisms of actions, new targeted delivery methods and safe but highly personalized therapeutic options to significantly improve or cure the disease.

Next generation healthcare technologies

Solutions that can make a real difference to healthcare payors facing increasing pressure from social burden


 

Holistic healthcare investment


Building businesses that fight chronic diseases on three fronts


 

Holistic Healthcare Investment

 

Digital Health


Using data to provide clinical grade actionable insight.

Diagnostics


Novel highly specific tests to provide earlier diagnosis, accurate monitoring of disease progression and the ability to personalize therapy based on an understanding of an individuals ability to respond to treatment.

Therapeutics


Novel mechanisms of actions, new targeted delivery methods and safe but highly personalized therapeutic options to significantly improve or cure the disease.

Next generation healthcare technologies


Solutions that can make a real difference to healthcare payors facing increasing pressure from social burden

→ About us

 

 

Business model
The business strategy is based on funding and building game-changing healthcare technology companies towards value inflection points and eventual exit including through a trade sale or public listing.

 

→ Our Team

→ Investors  

Netscientific condensed business model

 

Business model


The business strategy is based on funding and building game-changing healthcare technology companies towards value inflection points and eventual exit including through a trade sale or public listing.

NetScientific condensed business model

 

Our portfolio
Our portfolio companies are targeting chronic diseases
Vortex
Wanda
ProAxsis
Glycotest
Glucosense
Glucosense

 

Our portfolio


Our portfolio companies are targeting chronic diseases